Insiders · Profile

Zummo Jacqueline

Chief R&D Officer at Protara Therapeutics. Filing since 26 Mar 2025. CIK 0001798929

Company
Date
Role
Action
Shares
Amount
Of holding
8 Apr 2026
Chief R&D Officer
Sold at will
1,134
$6.12K
1.2%
1 Apr 2026
Chief R&D Officer
Sold at will
22,598
$118.87K
19.1%
26 Mar 2025
Chf Scientific Operations Off
Sold on a plan
21,224
$96.14K
17.7%
3 decisions on file.